Advertisement

Topics

Evaulate: Pricing Pressure Causes Worldwide Drug Sales Forecasts to Fall for First Time in 10 Years

09:00 EDT 20 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Fall comes as average cost of developing new drugs totals $4bn over the last 10 years Increased scrutiny around the pricing of medicines is starting to have an impact on drug sales growth, according to Evaluate’s latest Wo...

Other Sources for this Article

Media Contacts:
Evaluate and EP Vantage (for general questions)
Christine Lindgren
+1 617-866-3906
christine.lindgren@evaluategroup.com
or
Instinctif Partners (for non-U.S. media)
Gemma Harris/Melanie Toyne Sewell
+44 (0) 20 7457 2020
evaluate@instinctif.com
or
Jani Communications (for U.S. media)
Janice Foley
+1-617-823-5555
janifoley@verizon.net

NEXT ARTICLE

More From BioPortfolio on "Evaulate: Pricing Pressure Causes Worldwide Drug Sales Forecasts to Fall for First Time in 10 Years"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...